Buckley Wealth Management LLC Purchases Shares of 7,220 Walgreens Boots Alliance Inc (WBA)
Buckley Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,220 shares of the pharmacy operator’s stock, valued at approximately $524,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of WBA. Commonwealth Bank of Australia increased its holdings in shares of Walgreens Boots Alliance by 139.5% in the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after acquiring an additional 26,893 shares during the last quarter. Andra AP fonden increased its holdings in shares of Walgreens Boots Alliance by 6.9% in the 3rd quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock valued at $4,811,000 after acquiring an additional 4,000 shares during the last quarter. Birinyi Associates Inc. increased its holdings in shares of Walgreens Boots Alliance by 9.0% in the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after acquiring an additional 750 shares during the last quarter. Chesley Taft & Associates LLC increased its holdings in shares of Walgreens Boots Alliance by 48.6% in the 4th quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock valued at $18,981,000 after acquiring an additional 85,423 shares during the last quarter. Finally, CI Investments Inc. purchased a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $27,555,000. Institutional investors own 61.57% of the company’s stock.
In related news, insider Stefano Pessina acquired 98,858 shares of the firm’s stock in a transaction on Monday, January 15th. The stock was bought at an average cost of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. 14.80% of the stock is currently owned by company insiders.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. During the same period in the prior year, the firm earned $1.10 EPS. The business’s revenue was up 7.9% on a year-over-year basis. research analysts anticipate that Walgreens Boots Alliance Inc will post 5.71 earnings per share for the current year.
Walgreens Boots Alliance announced that its board has authorized a share repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company’s management believes its shares are undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.34%. Walgreens Boots Alliance’s payout ratio is 44.20%.
A number of research analysts have recently commented on WBA shares. Pivotal Research dropped their price objective on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a report on Tuesday, October 24th. Deutsche Bank started coverage on Walgreens Boots Alliance in a report on Monday, December 4th. They issued a “hold” rating and a $78.00 price objective on the stock. Vetr upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 target price for the company in a research report on Saturday, January 13th. Finally, Jefferies Group set a $93.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, October 29th. Ten research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. Walgreens Boots Alliance presently has an average rating of “Buy” and a consensus price target of $85.05.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.